Meijer Severe Menthol Throat Drops

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of occasional minor irritation and pain associated with sore throat and sore mouth.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children aged 12 years and over, the recommended dosage is to dissolve 1 drop slowly in the mouth. This may be repeated every two hours as needed or as directed by a healthcare professional.

The use of this medication is not recommended for children under 12 years of age.

Contraindications

Use of this product is contraindicated in patients who exceed the recommended dosage. Adhering to the prescribed dosage is essential to avoid potential adverse effects associated with overdose. No other specific contraindications have been identified.

Warnings and Precautions

Severe sore throat may indicate a more serious condition. If a patient experiences a sore throat that is severe, persists for more than 2 days, or is accompanied by fever, headache, rash, swelling, nausea, or vomiting, it is imperative to consult a healthcare professional promptly. The product should not be used for more than 2 days, and it is contraindicated for children under 12 years of age.

Healthcare professionals should advise patients to discontinue use and seek medical advice if symptoms such as a sore mouth do not improve within 7 days, or if there is persistent or worsening irritation, pain, or redness.

While no specific emergency medical help instructions are provided, it is essential for healthcare providers to remain vigilant and assess the need for immediate intervention based on the patient's clinical presentation.

Currently, there are no specific general precautions or laboratory tests associated with the use of this product. However, healthcare professionals should exercise clinical judgment and consider individual patient circumstances when recommending treatment.

Side Effects

Patients may experience a range of adverse reactions associated with the use of this product. Serious adverse reactions include severe sore throat, particularly if it is accompanied by difficulty in breathing, fever, headache, rash, swelling, nausea, or vomiting. In such cases, patients are advised to consult a doctor promptly.

Common adverse reactions may involve irritation, pain, or redness in the oral cavity. If these symptoms persist or worsen, patients should discontinue use and seek medical advice. Additionally, if a sore mouth does not improve within 7 days, it is recommended that patients consult a healthcare professional.

It is important to note that the product should not be used for more than 2 days, and it is contraindicated for children under 12 years of age. Patients should be vigilant for any severe symptoms and seek medical attention as necessary.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Meijer Severe Menthol Throat Drops (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should not use this medication. For patients aged 12 years and older, the recommended dosage is to dissolve 1 drop slowly in the mouth, with the option to repeat every two hours as needed or as directed by a healthcare professional. Caution is advised in the administration of this product to ensure safety and efficacy in the appropriate age group.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits, as well as any available data regarding fetal outcomes and lactation. Healthcare providers can offer guidance tailored to individual circumstances, ensuring the safety of both the patient and the developing fetus or nursing infant.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is no specific data available regarding the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific overdosage information, it is essential for healthcare professionals to remain vigilant and prepared for potential scenarios involving overdose.

Healthcare providers should be aware that the clinical presentation of an overdose may vary depending on the substance involved and the individual patient’s characteristics. Symptoms of overdose can include, but are not limited to, severe drowsiness, confusion, respiratory depression, and cardiovascular instability.

In the event of suspected overdosage, immediate medical evaluation is recommended. Healthcare professionals should assess the patient's vital signs and conduct a thorough clinical examination. Supportive care should be initiated as necessary, which may include airway management, oxygen supplementation, and intravenous fluids.

If specific antidotes or treatments are available for the substance involved, they should be administered according to established protocols. Continuous monitoring of the patient’s condition is crucial, and healthcare providers should be prepared to implement advanced life support measures if indicated.

It is advisable to consult local poison control centers or toxicology experts for guidance on managing overdose cases, as they can provide valuable insights and recommendations tailored to the specific situation.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

Adverse events have been reported voluntarily and through surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events by calling 1-800-245-2898, available Monday through Friday from 9 AM to 4 PM EST.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. Patients should be instructed to stop using the medication and consult a doctor if their sore mouth does not improve within 7 days, or if they experience persistent or worsening irritation, pain, or redness.

It is important to emphasize that patients should not exceed the recommended dosage of the medication. Additionally, healthcare providers should encourage patients to seek medical advice before using the product if they have a severe sore throat that is accompanied by difficulty in breathing or lasts more than 2 days. Patients should also be advised to consult a doctor if their sore throat is accompanied by fever, headache, rash, swelling, nausea, or vomiting.

Storage and Handling

The product is supplied in a secure bag, which must not be used if it is torn or open, as this may compromise the integrity of the contents.

Storage conditions require that the product be kept in a cool, dry place, away from direct sunlight and moisture. It is essential to handle the product with care to maintain its quality and efficacy.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Meijer Severe Menthol Throat Drops, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)